BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26024915)

  • 1. BRCC3 acts as a prognostic marker in nasopharyngeal carcinoma patients treated with radiotherapy and mediates radiation resistance in vitro.
    Tu Z; Xu B; Qu C; Tao Y; Chen C; Hua W; Feng G; Chang H; Liu Z; Li G; Jiang C; Yi W; Zeng M; Xia Y
    Radiat Oncol; 2015 May; 10():123. PubMed ID: 26024915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma.
    Qu C; Zhao Y; Feng G; Chen C; Tao Y; Zhou S; Liu S; Chang H; Zeng M; Xia Y
    J Cell Mol Med; 2017 Nov; 21(11):2872-2883. PubMed ID: 28557284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RPA1 downregulation enhances nasopharyngeal cancer radiosensitivity via blocking RAD51 to the DNA damage site.
    Zhang Z; Huo H; Liao K; Wang Z; Gong Z; Li Y; Liu C; Hu G
    Exp Cell Res; 2018 Oct; 371(2):330-341. PubMed ID: 30144445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of Annexin A1 Enhances Radioresistance and Inhibits Apoptosis in Nasopharyngeal Carcinoma.
    Liao L; Yan WJ; Tian CM; Li MY; Tian YQ; Zeng GQ
    Technol Cancer Res Treat; 2018 Jan; 17():1533034617750309. PubMed ID: 29357787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHAF1B induces radioresistance by promoting DNA damage repair in nasopharyngeal carcinoma.
    Di M; Wang M; Miao J; Chen B; Huang H; Lin C; Jian Y; Li Y; Ouyang Y; Chen X; Wang L; Zhao C
    Biomed Pharmacother; 2020 Mar; 123():109748. PubMed ID: 31869663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis.
    Huang T; Yin L; Wu J; Gu JJ; Wu JZ; Chen D; Yu HL; Ding K; Zhang N; Du MY; Qian LX; Lu ZW; He X
    J Exp Clin Cancer Res; 2016 Dec; 35(1):188. PubMed ID: 27919278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR‑495 enhances the efficacy of radiotherapy by targeting GRP78 to regulate EMT in nasopharyngeal carcinoma cells.
    Feng X; Lv W; Wang S; He Q
    Oncol Rep; 2018 Sep; 40(3):1223-1232. PubMed ID: 30015969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of phosphorylated Raf kinase inhibitory protein at serine 153 and its predictive effect on the clinical response to radiotherapy in nasopharyngeal carcinoma.
    Li S; Liu T; Mo W; Hou Q; Zhou Y; Liu M; He Z; Liu Z; Chen Q; Wang H; Guo X; Xia W; Zeng M; Zhao H
    Radiat Oncol; 2016 Sep; 11(1):121. PubMed ID: 27647315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of annexin VII enhances nasopharyngeal carcinoma cell radiosensitivity in vivo and in vitro.
    Gui SJ; Ding RL; Wan YP; Zhou L; Chen XJ; Zeng GQ; He CZ
    Cancer Biomark; 2020; 28(2):129-139. PubMed ID: 31958076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SALL4 induces radioresistance in nasopharyngeal carcinoma via the ATM/Chk2/p53 pathway.
    Nie X; Guo E; Wu C; Liu D; Sun W; Zhang L; Long G; Mei Q; Wu K; Xiong H; Hu G
    Cancer Med; 2019 Apr; 8(4):1779-1792. PubMed ID: 30907073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Far upstream element-binding protein 1 is a prognostic biomarker and promotes nasopharyngeal carcinoma progression.
    Liu ZH; Hu JL; Liang JZ; Zhou AJ; Li MZ; Yan SM; Zhang X; Gao S; Chen L; Zhong Q; Zeng MS
    Cell Death Dis; 2015 Oct; 6(10):e1920. PubMed ID: 26469968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy.
    Huang PY; Zeng TT; Ban X; Li MQ; Zhang BZ; Zhu YH; Hua WF; Mai HQ; Zhang L; Guan XY; Li Y
    BMC Cancer; 2016 Aug; 16(1):669. PubMed ID: 27549330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of β-Catenin Decreases the Radiosensitivity of Human Nasopharyngeal Carcinoma CNE-2 Cells.
    He H; Lin K; Su Y; Lin S; Zou C; Pan J; Zhou Y; Chen C
    Cell Physiol Biochem; 2018; 50(5):1929-1944. PubMed ID: 30396174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53R2 as a novel prognostic biomarker in nasopharyngeal carcinoma.
    Chen J; Li S; Xiao Y; Zou X; Zhang X; Zhu M; Cai M; Xie D
    BMC Cancer; 2017 Dec; 17(1):846. PubMed ID: 29237424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting ERp29 expression enhances radiosensitivity in human nasopharyngeal carcinoma cell lines.
    Qi L; Wu P; Zhang X; Qiu Y; Jiang W; Huang D; Liu Y; Tan P; Tian Y
    Med Oncol; 2012 Jun; 29(2):721-8. PubMed ID: 21479953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide analyses of long noncoding RNA expression profiles correlated with radioresistance in nasopharyngeal carcinoma via next-generation deep sequencing.
    Li G; Liu Y; Liu C; Su Z; Ren S; Wang Y; Deng T; Huang D; Tian Y; Qiu Y
    BMC Cancer; 2016 Sep; 16(1):719. PubMed ID: 27599611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of prognostic biomarkers for response to radiotherapy by DNA microarray in nasopharyngeal carcinoma patients.
    Yang S; Chen J; Guo Y; Lin H; Zhang Z; Feng G; Hao Y; Cheng J; Liang P; Chen K; Wu H; Li Y
    Int J Oncol; 2012 May; 40(5):1590-600. PubMed ID: 22267178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regenerating gene IA predicts radiosensitivity and survival in nasopharyngeal carcinoma.
    Xing HJ; Chen XD; Sun HX; Dai YZ; Han YF; Ding LL; Liu JH; Chen HB
    J Physiol Pharmacol; 2022 Feb; 73(1):. PubMed ID: 35793764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cofilin-2 Acts as a Marker for Predicting Radiotherapy Response and Is a Potential Therapeutic Target in Nasopharyngeal Carcinoma.
    Yu BB; Lin GX; Li L; Qu S; Liang ZG; Chen KH; Zhou L; Lu QT; Sun YC; Zhu XD
    Med Sci Monit; 2018 Apr; 24():2317-2329. PubMed ID: 29664897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A five-variable signature predicts radioresistance and prognosis in nasopharyngeal carcinoma patients receiving radical radiotherapy.
    Yi HM; Yi H; Zhu JF; Xiao T; Lu SS; Guan YJ; Xiao ZQ
    Tumour Biol; 2016 Mar; 37(3):2941-9. PubMed ID: 26409455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.